Fast-tracking Emerging NSCLC Immunotherapy Evidence into Practice

PROGRAM DESCRIPTION MediBrief: Fast-tracking Emerging Non-Small Cell Lung Cancer (NSCLC) Immunotherapy Evidence into Practice is an educational activity that provides clinicians with ways to quickly act on key summarized interpretations ...

PROGRAM DESCRIPTION
MediBrief: Fast-tracking Emerging Non-Small Cell Lung Cancer (NSCLC) Immunotherapy Evidence into Practice is an educational activity that provides clinicians with ways to quickly act on key summarized interpretations and fair/balanced, evidence-based recommendations about issues pertaining to NSCLC immunotherapy. All information is prepared in brief, but concise and clinically accurate portions that are sensitive to the time constraints of busy clinicians. At the end of each brief summarized pearl, clinically accurate and relevant suggestions posed as short call-out examples are provided, as a means to bring suggested options to practice. Clinicians may digest and apply these suggestions to real-life practice for personalized NSCLC management.

EDUCATIONAL OBJECTIVES
After completing this activity, the participant should be better able to:Identify the use of biomarkers that may help select those patients most likely to benefit from current and emerging NSCLC targeted treatments and cancer immunotherapiesDiscuss the advances made in NSCLC immunotherapy research that could impact targeted treatment decisions made by the inter-professional oncology teamEvaluate the clinical utility of lung cancer immunotherapy

---

Write the first review

Resource tags